Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A recombinant subunit vaccine approach to HCMV vaccine development.

× No keyword cloud information.

21 in total

1. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Authors: W J Britt; L G Vugler
Journal: J Virol Date: 1992-11 Impact factor: 5.103

2. Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.

Authors: Daniel J Hackett; Changpin Zhang; Carla Stefanescu; Robert F Pass
Journal: Clin Vaccine Immunol Date: 2010-03-10

3. Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?

Authors: Mark R Schleiss
Journal: J Infect Dis Date: 2011-06-01 Impact factor: 5.226

4. Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB.

Authors: N Norais; J A Hall; L Gross; D Tang; S Kaur; S H Chamberlain; R L Burke; F Marcus
Journal: J Virol Date: 1996-08 Impact factor: 5.103

5. Searching for a Serological Correlate of Protection for a CMV Vaccine.

Authors: M R Schleiss
Journal: J Infect Dis Date: 2018-05-25 Impact factor: 5.226

Review 6. The history of vaccination against cytomegalovirus.

Authors: Stanley Plotkin
Journal: Med Microbiol Immunol Date: 2015-03-20 Impact factor: 3.402

Review 7. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors: Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal: Clin Microbiol Rev Date: 2009-01 Impact factor: 26.132

Review 8. Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant.

Authors: Robert F Pass
Journal: J Clin Virol Date: 2009-07-31 Impact factor: 3.168

Review 9. Cytomegalovirus vaccine development.

Authors: M R Schleiss
Journal: Curr Top Microbiol Immunol Date: 2008 Impact factor: 4.291

10. Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.

Authors: Xinle Cui; Zhouhong Cao; Shuishu Wang; Ronzo B Lee; Xiao Wang; Haruhiko Murata; Stuart P Adler; Michael A McVoy; Clifford M Snapper
Journal: Vaccine Date: 2018-08-03 Impact factor: 3.641